IP Library Granted Patent US 10,358,673
Granted Patent B2
US 10,358,673 · App. 15/358,841 · Granted Jul 23, 2019

Method of amplifying nucleic acid sequences

Inventor: Kevin J. McKernan (Marblehead, MA)
Assignee: Courtagen Life Sciences, Inc.
C12Q1/6806C12Q1/686C12Q1/6848
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,358,673
App. No.
15/358,841
Granted
Jul 23, 2019
Kind
B2
Abstract

The invention is directed to methods of removing amplicons of non target and/or target nucleic acid sequences having one or more modified (e.g., methylated) nucleotides from a sample wherein the sample comprises the non target nucleic acid and a target nucleic acid sequence to be amplified.

Claims (21)

1. A method of removing amplicons of a non target nucleic acid having one or more cytosines that are methylated from a sample wherein the sample comprises amplicons of the non target nucleic acid and genomic DNA that includes a target nucleic acid to be serially amplified, the target nucleic acid having one or more methylated cytosines, comprising

a) contacting the sample with a composition comprising (i) deoxynucleotide triphophates (dNTPs) comprising dATP, dTTP, dGTP, and dCTP wherein one or more of the dCTP nucleotides are methylated with a first methyl group (ii) a nucleic acid polymerase, (iii) one or more primers that are complementary to a portion of the target nucleic acid, and (iv) a first methyl specific restriction enzyme that is capable of being deactivated and that digests nucleic acids comprising nucleotides that are methylated with the first methyl group, thereby producing a combination;

b) maintaining the combination under conditions in which the amplicons of the non target nucleic acid are digested by the first methyl specific restriction enzyme prior to amplification of the genomic DNA that includes the target nucleic acid;

c) amplifying the genomic DNA that includes the target nucleic acid, thereby producing amplicons of the target nucleic acid having one or more nucleotides that are methylated with the first methyl group;

d) contacting the amplicons of the target nucleic acid with a composition comprising (i) deoxynucleotide triphophates (dNTPs) comprising dATP, dTTP, dGTP, and dCTP wherein one or more of the dCTP nucleotides are methylated with a second methyl group (ii) a nucleic acid polymerase, (iii) one or more primers that are complementary to a portion of the target nucleic acid, and (iv) a second methyl specific restriction enzyme that is capable of being deactivated and that selectively digests nucleic acids comprising nucleotides that are methylated with the second methyl group, thereby producing a combination;

e) maintaining the combination of e) under conditions in which the amplicons of the non target nucleic acid are digested by the second methyl specific restriction enzyme prior to amplification of the genomic DNA that includes the target nucleic acid; and

f) amplifying the genomic DNA that includes the target nucleic acid, thereby producing amplicons of the target nucleic acid having one or more nucleotides that are methylated with the first methyl group and the second methyl group,

wherein the amplicons of the non target nucleic acid are removed from the sample comprising the genomic DNA that includes the target nucleic acid to be serially amplified.

2. The method of claim 1 , wherein the methyl specific restriction enzyme is deactivated upon a change in temperature, a change in pH, contact with a reagent or a combination thereof.

3. The method of claim 1 , wherein the dCTP nucleotides that are methylated with a first methyl group are 5-methyl cytosine nucleotides, and the dCTP nucleotides that are methylated with a second methyl group are 5-hydroxymethyl cytosine nucleotides.

4. The method of claim 1 , wherein the first methyl specific restriction enzyme is selected from the group consisting of MspJ1, FspE1, LpnPI, AspBHI, RlaI, SgrTI, and AbaSI.

5. The method of claim 1 , wherein the second methyl specific restriction enzyme is selected from the group consisting of MspJ1, FspE1, LpnPI, AspBHI, RlaI, SgrTI, and AbaSI.

6. The method of claim 3 , wherein the first methyl specific restriction enzyme is MspJI.

7. The method of claim 3 , wherein the second methyl specific restriction enzyme is AbaSI.

8. The method of claim 6 , wherein the second methyl specific restriction enzyme is AbaSI.

9. The method of claim 1 , wherein the composition of a) further comprises one or more reagents that alters the melting temperature.

10. The method of claim 9 , wherein the one or more reagents comprises dimethyl sulfoxide (DMSO), Tri-methyl glycine (Betaine) or a combination thereof.

11. The method of claim 1 , wherein the non target nucleic acid is double stranded.

12. The method of claim 1 , wherein the non-target nucleic acid is a nucleic acid library, genomic nucleic acid, or mitochondrial nucleic acid, or a combination thereof.

13. The method of claim 1 , wherein the genomic DNA that includes the target nucleic acid is denatured prior to amplification.

14. The method of claim 1 , wherein the target nucleic acid is amplified for at least 1 amplification cycle, wherein each amplification cycle comprises 12° C. for 60 seconds, 98° C. for 20 seconds, 60° C. for 15 seconds, 72° C. for 60 seconds, 12 sequencing cycles at 98° C. for 20 seconds, 72° C. for 3 minutes.

Assignments (2)
CHANGE OF NAME Recorded Jan 18, 2022
From: COURTAGEN LIFE SCIENCES, INC.
To: MEDICINAL GENOMICS CORPORATION
Reel/Frame 058921/0713 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 4, 2017
From: MCKERNAN, KEVIN J.
To: COURTAGEN LIFE SCIENCES, INC.
Reel/Frame 042237/0438 →
Continuity (5)
Continuation 15099230 · Apr 14, 2016
Continuation 14341540 · Jul 25, 2014
Continuation PCTUS2013063931 · Oct 8, 2013
Provisional Application 61729072 · Nov 21, 2012
Related Publication 20170073732A1 · Mar 16, 2017